Competition and Markets Authority v Flynn Pharma Ltd & Anor

Link copied
Case Copied 91 min read

Appellants (Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd)

Daniel Jowell QC

Tom Pascoe

(Instructed by Macfarlanes LLP)

Appellants (Pfizer Inc and Pfizer Ltd)

Mark Brealey QC

Tim Johnston

(Instructed by Clifford Chance LLP (London))

Respondent (Competition and Markets Authority)

Sir James Eadie QC

Rob Williams QC

David Bailey

Rupert Paines

(Instructed by Competition and Markets Authority)

1st Interveners (Association of the British Pharmaceutical Industry (ABPI) and British Generic Manufacturers Association (BGMA))

(written submissions only)

Daniel Piccinin

(Instructed by Bristows LLP (London))

2nd Intervener (Office of Communications (Ofcom))

(written submissions only)

Josh Holmes QC

Jessica Boyd

(Instructed by OFCOM)

3rd Intervener (Solicitors Regulation Authority Ltd (SRA))

(written submissions only)

Andrew Tabachnik QC

Ruth Keating

(Instructed by Solicitors Regulation Authority Ltd)

4th Intervener (Oakridge Farms Ltd)

(written submissions only)

Charles Streeten

(Instructed by Woodfines LLP (Milton Keynes))

 

LADY ROSE: (with whom Lord Hodge, Lord Sales, Lord Leggatt and Lord Stephens agree)

    1.         INTRODUCTION

  1. The appellants in these proceedings were successful in an appeal which they brought before the Competition Appeal Tribunal (“the CAT”) under section 46 of the Competition Act 1998. In that appeal they challenged a decision adopted by the Respondent (“the CMA”) fining them for an infringement of competition law.
  2. The CAT allowed the appellants’ appeal in part, set aside part of the CMA’s decision and remitted the decision to the CMA for reconsideration. On the appellants’ application for their costs of the appeal, the CAT made an order that the CMA pay the appellants a proportion of those costs. The Court of Appeal in the judgment now under appeal before this court set aside the CAT’s costs order and directed that there be no order as to costs. The Court of Appeal held that the CAT had erred in ordering the CMA to pay the appellants’ costs because it had disregarded a principle derived from a line of cases starting with Bradford Metropolitan District Council v Booth [2000] 164 JP 485. That principle was, the Court of Appeal held, that where, as here, a tribunal’s power to make an order about costs does not include an express general rule or default position, the starting point is that no order for costs should be made against a public body that has been unsuccessful in bringing or defending proceedings in the exercise of its statutory functions.
  3. The appellants now appeal to this court arguing that the Court of Appeal was wrong to hold that the CAT’s discretion as to what costs order to make was constrained by any such principle. They argue that there is no such principle and that what is established by the case law is only that an important factor for a court or tribunal to take into account when considering costs is whether there is a risk that making adverse costs orders will have a “chilling effect” on the conduct of the public body concerned. By a risk of “chilling effect” they mean that the respondent public body might be so concerned about the…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Competition and Markets Authority v Flynn Pharma Ltd & Anor and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2022] UKSC 14
Decision Date

CaseChat Overview and Summary

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established